Cannabinoid use among Americans with MS: Current trends and gaps in knowledge.

Tiffany J BraleyDaniel WhibleyKevin N Alschuler Dawn M EhdeRonald D ChervinDaniel J ClauwDavid WilliamsAnna L Kratz

Published in: Multiple sclerosis journal - experimental, translational and clinical (2020)

Cannabinoid use is common in PwMS, despite a paucity of provider guidance. The range of perceived benefits, and potential differential effects of THC and CBD, highlight the need for personalized, evidence-based guidelines regarding cannabinoid use.

Keyphrases

healthcare
primary care
mass spectrometry
multiple sclerosis
depressive symptoms
social support
mental health
physical activity
ms ms
clinical practice
risk assessment
human health